Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 01/21/2022

Closing price: 220.52

Support price level:	N/A
Resistance price level:	$238.00
Relative strength index (14-day RSI)	36.8
Beta	0.82

BIIB is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
With a -18.2 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
Volatility is forecast to fall over the next month.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$220.52	$414.71	0.0%

200 day	50 day	20 day	10 day
$292.20	$240.44	$236.40	$232.18

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
44.6%	37.8%	42.7%	46.8%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: